A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1994
12/22/1994	WO1994028865A1 High foaming oral composition
12/22/1994	WO1994028726A2 Method of treating retained pulmonary secretions
12/22/1994	WO1994028721A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
12/22/1994	WO1994028714A1 Method of killing fungi, yeast or bacteria with selected monocyclic monoterpenes
12/22/1994	WO1994025588A3 ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-β (TGF-β)
12/22/1994	WO1994025477A3 Novel peptide nucleic acids
12/22/1994	WO1994025029A3 Use of sabeluzole in chronic neurodegenerative diseases
12/22/1994	WO1994025012A3 Medicaments for treatment of migraine, epilepsy and feeding disorders
12/22/1994	WO1994022835A3 Heterocyclic compounds as platelet aggregation inhibitors
12/22/1994	WO1994022483A3 Prodrugs with enhanced penetration into cells
12/22/1994	WO1994018972A3 Methods for treating neurodegenerative diseases and disorders using n-(2,6-disubstituted aromatic)-n'-pyridinyl ureas and other anticonvulsant compounds
12/22/1994	DE4420856A1 Pharmaceutical composition with analgesic activity
12/22/1994	DE4420690A1 Use of chaulmoogra oils in cosmetics and pharmacy, in particular dermatology for equalising the pigmentation of the skin
12/22/1994	DE4320117A1 Combination products
12/22/1994	CA2566543A1 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia
12/22/1994	CA2165344A1 Immune stimulants in bacterial infections
12/22/1994	CA2165325A1 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
12/22/1994	CA2165324A1 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
12/22/1994	CA2165159A1 Analgesic dibenzoxazepines and dibenzothiazepines
12/22/1994	CA2164969A1 Method of killing fungi, yeast or bacteria with selected monocyclic monoterpenes
12/22/1994	CA2164953A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives
12/22/1994	CA2164875A1 New active compounds
12/22/1994	CA2164843A1 Novel therapeutic drug delivery systems
12/22/1994	CA2164837A1 Therapeutic compositions and methods of use
12/22/1994	CA2164827A1 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose
12/22/1994	CA2164733A1 Methods and compositions for lowering intraocular pressure
12/22/1994	CA2164641A1 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection
12/22/1994	CA2164639A1 A novel use of ambasilide
12/22/1994	CA2164632A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
12/22/1994	CA2164606A1 Compositions for use in the regulation of subnormal ph values in the intestinal tract and for treatment of bowel diseases
12/22/1994	CA2164583A1 Imidazole 5-position substituted angiotensin ii antagonists
12/22/1994	CA2164319A1 Arylpyrazoles fongicides
12/22/1994	CA2164317A1 Use of natural products and related synthetic compounds for the treatment of cardiovascular disease
12/22/1994	CA2164314A1 Cephalostatin analogues and their use as anti-tumour agents
12/22/1994	CA2164288A1 Method for treating kaposi's sarcoma with antisense oligonucleotides
12/22/1994	CA2164119A1 1-substituted isatin and oxindole derivatives as inhibitors of acetylcholinesterase
12/22/1994	CA2164009A1 Secondary amines as antidiabetic and antiobesity agents
12/22/1994	CA2163995A1 Spiro-substituted azacycles as neurokinin antagonists
12/22/1994	CA2163447A1 Antiparasitic agents
12/22/1994	CA2163121A1 Extended release, film-coated tablet of astemizole and pseudoephedrine
12/22/1994	CA2163018A1 N-[[1-[4-(4-fluorophenoxy)butyl] -4-piperidinyl]-n-methylamino]-2-benzothiazolols as class iii antiarrhythmic agents
12/22/1994	CA2163011A1 New peptides derivatives
12/22/1994	CA2162497A1 Adenoviral vectors for treatment of hemophilia
12/22/1994	CA2161960A1 14-substituted marcfortines and derivatives useful as antiparasitic agents
12/22/1994	CA2161328A1 Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them
12/22/1994	CA2161325A1 Pyrimidine, cyanoguandines as k-channel blockers
12/22/1994	CA2161251A1 Benz(b)azepine-2,5-diones useful in the treatment of neurodegenerative disorders
12/22/1994	CA2160368A1 Preparations containing silicon dioxide to improve the taste thereof
12/22/1994	CA2140660A1 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
12/22/1994	CA2140553A1 Amino acid derivative
12/22/1994	CA2126294A1 Materials and methods for screening anti-osteoporosis agents
12/22/1994	CA2126166A1 Substituted monopyridylmethyl and bipyridylmethyl derivatives
12/21/1994	EP0629697A2 Materials and methods for screening anti-osteoporosis agents
12/21/1994	EP0629696A1 Recombinant DNA-derived bordetella toxin subunit analogs
12/21/1994	EP0629635A1 New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them
12/21/1994	EP0629633A2 Dinucleotide analogues, intermediates therefor and oligonucleotides derived therefrom
12/21/1994	EP0629627A2 Bicyclic carboxylic acids and their derivatives as nep and aca inhibitors
12/21/1994	EP0629625A1 Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
12/21/1994	EP0629624A1 Tetrazole derivatives, their production and use
12/21/1994	EP0629604A2 Alicyclic phospholipase A2 inhibitors
12/21/1994	EP0629602A1 3,4-Dihydroxychalcone derivatives
12/21/1994	EP0629409A1 Tetrapyrrole carboxylic acid derivatives for diagnosis and/or therapy of arthritis
12/21/1994	EP0629408A1 Combination of angiotensin converting enzyme inhibitors and AII antagonists
12/21/1994	EP0629405A1 Agent for inhibiting a decrease in bone mass in renal osteodystrophy
12/21/1994	EP0629404A1 Pharmaceutical composition containing cefditoren pivoxil
12/21/1994	EP0629403A1 Antibiotic combination
12/21/1994	EP0629402A1 Pharmaceutical compositions containing ipsapirone
12/21/1994	EP0629401A1 Use of 1,2,4-dithiazolium salts as chemotherapeutics, particularly as TNF-inhibitors, and now 1,2,4-dithiazolium salts
12/21/1994	EP0629400A1 Idebenone compositions for treating Alzheimer's disease
12/21/1994	EP0629399A1 Treatment and control of ocular development with cholinergic agonists
12/21/1994	EP0629398A1 Pharmaceutical preparation for controlled release of a medicinal compound at a targeted site in the intestinal tract
12/21/1994	EP0629397A1 Cosmetic or pharmaceutical composition for topical application active against free radicals
12/21/1994	EP0629211A1 4-oxo-2 thioxoimidazolidine derivates as inhibitors of blood platelet aggregation
12/21/1994	EP0629210A1 Peptide linkage unit comprising methylene phosphinic acid
12/21/1994	EP0629208A1 Fluorosugar derivatives of macrolides
12/21/1994	EP0629204A1 Cephalosporin derivatives
12/21/1994	EP0629203A1 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents
12/21/1994	EP0629202A1 Antiparasitic avermectin and milbemycin derivatives.
12/21/1994	EP0629200A1 Epibatidine and derivatives, compositions and methods of treating pain
12/21/1994	EP0629199A1 Indole derivatives as 5-ht1 agonists
12/21/1994	EP0629198A1 Nitrogen containing heterocyclic compounds useful as pharmaceuticals
12/21/1994	EP0629196A1 Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them
12/21/1994	EP0629190A1 Compounds as calcium channel antagonists
12/21/1994	EP0629184A1 TETRALIN DERIVATIVES AS HMG-CoA REDUCTASE INHIBITORS
12/21/1994	EP0629132A1 PURIFIED VACUOLATING TOXIN FROM $i(HELICOBACTER) PYLORI AND METHODS TO USE SAME
12/21/1994	EP0629129A1 Method for kidney tubulogenesis
12/21/1994	EP0626866A4 The use of carotenoporphyrins as tumor localizing agents for diagnosis, visualization and delivery of sensitizers to tumor tissues.
12/21/1994	EP0610368A4 Treatment of acne or of pseudofolliculitis barbae.
12/21/1994	EP0478787B1 Novel process for producing benzoic acid derivative
12/21/1994	EP0424525B1 Novel amines and their use
12/21/1994	CN1096584A Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of hla-c-clone 10/mage-1 derived peptides, and method for treating said.........
12/21/1994	CN1096513A Endothelin receptor antagonists
12/21/1994	CN1096511A Process for the preparation of biphenyl derivatives
12/21/1994	CN1096443A Anti-atherosclerotic use of 17 alpha-dihydroeoquilin
12/21/1994	CN1027068C Alpha-substituted 4-(quinolin-2-yl-methoxy)-phenylacetic acide and-esters
12/21/1994	CN1027066C Method for manufacturing of novel indole derivative
12/21/1994	CN1027065C Tetralin esters of phenols or benzoic acids
12/20/1994	US5374772 Substituted benzoic acids, inhibitors of phospholipases A2
12/20/1994	US5374746 L-talopyranoside derivatives and process for the preparation of same
12/20/1994	US5374739 Mitomycin analogs

1 ... 7057 7058 7059 7060 7061 7062 7063 7064 7065 7066 7067 7068 7069 7070 7071 7072 7073 7074 7075 7076 7077 ... 7860